Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
Recruiting · NCT07093606 · Registry updated 2025-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Not applicable | 2025-07-30 | NCT07093606 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sohag University | 409 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sohag University Hospital | Sohag | Egypt | 62 |